UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

____________________

FORM 8‑K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

February 16, 2017

____________________

National Instruments Corporation
(Exact name of registrant as specified in its charter)

Delaware
 
000-25426
 
74-1871327
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification No.)

11500 North MoPac Expressway
Austin, Texas 78759
(Address of principal executive offices, including zip code)

(512) 338-9119
(Registrant's telephone number, including area code)

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





Item 2.02
 Results of Operations and Financial Condition.

On January 26, 2017, National Instruments Corporation ("NI") furnished financial information pursuant to Item 2.02 of Form 8-K (the "Form 8-K") regarding financial results for NI's fourth fiscal quarter ended December 31, 2016.  Based on NI's additional analysis of its calculation for provision for income taxes for the three and twelve-month periods ended December 31, 2016, NI is furnishing in the tables below revisions to certain of the financial information included in its Form 8-K.

The additional analysis referred to above did not impact NI's financial guidance included in the Form 8-K and NI is confirming, as of the date hereof, its financial guidance previously furnished in the Form 8-K dated January 26, 2017.

The information herein shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

NI's audited financial results for the year ended December 31, 2016 will be contained in its Annual Report on Form 10-K which is expected to be filed with the Securities and Exchange Commission on or about the date hereof.

A reconciliation of the financial information previously furnished in the Form 8-K on January 26, 2017 to the revised financial information is detailed in the tables below;

National Instruments
 
Condensed Consolidated Balance Sheets
 
(in thousands)
 
 
                 
 
 
December 31, 2016 (Unaudited)
 
 
 
As furnished on January 26, 2017
   
Impact of revision
   
As furnished on February 16, 2017
 
Assets
                 
Current assets:
                 
Cash and cash equivalents
   
285,283
           
285,283
 
Short-term investments
   
73,117
           
73,117
 
Accounts receivable, net
   
228,686
           
228,686
 
Inventories, net
   
193,608
           
193,608
 
Prepaid expenses and other current assets
   
54,056
     
(103
)
   
53,953
 
Total current assets
   
834,750
     
(103
)
   
834,647
 
 
                       
Property and equipment, net
   
260,456
             
260,456
 
Goodwill
   
253,197
             
253,197
 
Intangible assets, net
   
108,663
             
108,663
 
Other long-term assets
   
39,601
             
39,601
 
Total assets
   
1,496,667
     
(103
)
   
1,496,564
 
 
                       
Liabilities and Stockholders' Equity
                       
Current liabilities:
                       
Accounts payable
   
48,800
             
48,800
 
Accrued compensation
   
27,743
             
27,743
 
Deferred revenue - current
   
115,577
             
115,577
 
Accrued expenses and other liabilities
   
32,289
     
708
     
32,997
 
Other taxes payable
   
34,958
             
34,958
 
Total current liabilities
   
259,367
     
708
     
260,075
 
 
                       
Long-term debt
   
25,000
             
25,000
 
Deferred income taxes
   
41,733
     
3,653
     
45,386
 
Liability for uncertain tax positions
   
11,719
             
11,719
 
Deferred revenue - long-term
   
29,752
             
29,752
 
Other long-term liabilities
   
10,413
             
10,413
 
Total liabilities
   
377,984
     
4,361
     
382,345
 
 
                       
Stockholders' equity:
                       
Preferred stock
   
-
             
-
 
Common stock
   
1,292
             
1,292
 
Additional paid-in capital
   
771,346
             
771,346
 
Retained earnings
   
380,883
     
(4,681
)
   
376,202
 
Accumulated other comprehensive loss
   
(34,838
)
   
217
     
(34,621
)
Total stockholders' equity
   
1,118,683
     
(4,464
)
   
1,114,219
 
Total liabilities and stockholders' equity
   
1,496,667
     
(103
)
   
1,496,564
 

 


National Instruments
 
Condensed Consolidated Statements of Income
 
(in thousands, except per share data, unaudited)
 
                                     
   
Three Months Ended Dec. 31, 2016
   
Year Ended Dec. 31, 2016
 
   
As furnished on January 26, 2017
   
Impact of revision
   
As furnished on February 16, 2017
   
As furnished on January 26, 2017
   
Impact of revision
   
As furnished on February 16, 2017
 
Net sales:
                                   
Product
   
300,218
           
300,218
     
1,116,703
           
1,116,703
 
Software maintenance
   
28,314
           
28,314
     
111,476
           
111,476
 
Total net sales
   
328,532
           
328,532
     
1,228,179
           
1,228,179
 
                                             
Cost of sales:
                                           
Product
   
81,468
           
81,468
     
306,730
           
306,730
 
Software maintenance
   
1,264
           
1,264
     
6,391
           
6,391
 
Total cost of sales
   
82,732
           
82,732
     
313,121
           
313,121
 
                                             
Gross profit
   
245,800
           
245,800
     
915,058
           
915,058
 
                                             
Operating expenses:
                                           
Sales and marketing
   
115,006
           
115,006
     
461,236
           
461,236
 
Research and development
   
57,461
           
57,461
     
235,706
           
235,706
 
General and administrative
   
24,082
           
24,082
     
98,390
           
98,390
 
Total operating expenses
   
196,549
           
196,549
     
795,332
           
795,332
 
                                             
Operating income
   
49,251
           
49,251
     
119,726
           
119,726
 
                                             
Other income (expense):
                                           
Interest income
   
335
           
335
     
1,122
           
1,122
 
Net foreign exchange loss
   
(3,162
)
         
(3,162
)
   
(4,632
)
         
(4,632
)
Other income (expense), net
   
471
           
471
     
(1,581
)
         
(1,581
)
                                             
Income before income taxes
   
46,895
           
46,895
     
114,635
           
114,635
 
                                             
Provision for income taxes
   
13,065
     
4,681
     
17,746
     
27,220
     
4,681
     
31,901
 
                                                 
Net income
   
33,830
     
(4,681
)
   
29,149
     
87,415
     
(4,681
)
   
82,734
 
                                                 
Basic earnings per share
   
0.26
     
(0.03
)
   
0.23
     
0.68
     
(0.04
)
   
0.64
 
Diluted earnings per share
   
0.26
     
(0.03
)
   
0.23
     
0.68
     
(0.04
)
   
0.64
 
                                                 
Weighted average shares outstanding -
                                               
Basic
   
129,108
             
129,108
     
128,453
             
128,453
 
Diluted
   
129,503
             
129,503
     
129,008
             
129,008
 



National Instruments
 
Condensed Consolidated Statements of Cash Flows
 
(in thousands, unaudited)
 
 
                 
 
 
Year Ended Dec. 31, 2016
 
 
 
As furnished on January 26, 2017
   
Impact of revision
   
As furnished on February 16, 2017
 
 
                 
Cash flow from operating activities:
                 
Net income
   
87,415
     
(4,681
)
   
82,734
 
Adjustments to reconcile net income to net cash provided by operating activities:
           
-
         
Depreciation and amortization
   
73,390
     
-
     
73,390
 
Stock-based compensation
   
25,832
     
-
     
25,832
 
Tax expense/(benefit) expense from deferred income taxes
   
(22,751
)
   
17,321
     
(5,430
)
Tax benefit from stock option plans
   
(442
)
   
-
     
(442
)
Acquisition-related fair value adjustments
   
1,585
     
-
     
1,585
 
Net change in operating assets and liabilities
   
30,811
     
(12,640
)
   
18,171
 
Net cash provided by operating activities
   
195,840
     
-
     
195,840
 
 
                       
Cash flow from investing activities:
                       
Capital expenditures
   
(44,425
)
           
(44,425
)
Capitalization of internally developed software
   
(31,859
)
           
(31,859
)
Additions to other intangibles
   
(2,342
)
           
(2,342
)
Acquisitions, net of cash received
   
(549
)
           
(549
)
Purchases of short-term investments
   
(39,097
)
           
(39,097
)
Sales and maturities of short-term investments
   
47,769
             
47,769
 
Net cash used by investing activities
   
(70,503
)
   
-
     
(70,503
)
 
                       
Cash flow from financing activities:
                       
Proceeds from revolving line of credit
   
15,000
             
15,000
 
Principal payments on revolving line of credit
   
(27,000
)
           
(27,000
)
Proceeds from issuance of common stock
   
28,907
             
28,907
 
Repurchase of common stock
   
(5,635
)
           
(5,635
)
Dividends paid
   
(102,897
)
           
(102,897
)
Tax benefit from stock option plans
   
442
             
442
 
Net cash used by financing activities
   
(91,183
)
   
-
     
(91,183
)
 
                       
Net change in cash and cash equivalents
   
34,154
             
34,154
 
Cash and cash equivalents at beginning of year
   
251,129
             
251,129
 
Cash and cash equivalents at end of year
   
285,283
     
-
     
285,283
 



National Instruments
 
Reconciliation of GAAP to Non-GAAP Measures
 
(in thousands, unaudited)
 
 
                                   
Reconciliation of Provision for income taxes to Non-GAAP Provision for income taxes
                         
 
                                   
 
 
Three Months Ended Dec. 31, 2016
   
Year Ended Dec. 31, 2016
 
 
 
As furnished on January 26, 2017
   
Impact of revision
   
As furnished on February 16, 2017
   
As furnished on January 26, 2017
   
Impact of revision
   
As furnished on February 16, 2017
 
Provision for income taxes, as reported
   
13,065
     
4,681
     
17,746
     
27,220
     
4,681
     
31,901
 
Stock-based compensation
   
1,125
     
-
     
1,125
     
7,322
     
-
     
7,322
 
Amortization of acquisition intangibles
   
(855
)
   
-
     
(855
)
   
(2,162
)
   
-
     
(2,162
)
Acquisition transaction costs, restructuring charges, and other
   
94
     
-
     
94
     
1,452
     
-
     
1,452
 
Acquisition-related fair value adjustments
   
567
     
-
     
567
     
567
     
-
     
567
 
Non-GAAP provision for income taxes
   
13,996
     
4,681
     
18,677
     
34,399
     
4,681
     
39,080
 



Reconciliation of GAAP Net Income, Basic EPS and Diluted EPS to Non-GAAP Net Income, Non-GAAP Basic EPS and Non-GAAP Diluted EPS
 
(in thousands, except per share data, unaudited)
 
 
                                   
 
 
Three Months Ended Dec. 31, 2016
   
Year Ended Dec. 31, 2016
 
 
 
As furnished on January 26, 2017
   
Impact of revision
   
As furnished on February 16, 2017
   
As furnished on January 26, 2017
   
Impact of revision
   
As furnished on February 16, 2017
 
 
                                   
Net income, as reported
   
33,830
     
(4,681
)
   
29,149
     
87,415
     
(4,681
)
   
82,734
 
Adjustments to reconcile net income to non-GAAP net income:
                                               
  Stock-based compensation, net of tax effect
   
5,069
     
-
     
5,069
     
18,444
     
-
     
18,444
 
  Amortization of acquisition intangibles, net of tax effect
   
3,350
     
-
     
3,350
     
15,234
     
-
     
15,234
 
  Acquisition transaction costs, restructuring, and other, net of tax effect
   
242
     
-
     
242
     
2,812
     
-
     
2,812
 
   Acquisition-related fair value adjustments, net of tax effect
   
1,018
     
-
     
1,018
     
1,018
     
-
     
1,018
 
Non-GAAP net income
   
43,509
     
(4,681
)
   
38,828
     
124,923
     
(4,681
)
   
120,242
 
 
                                               
Basic EPS, as reported
   
0.26
     
(0.03
)
   
0.23
     
0.68
     
(0.04
)
   
0.64
 
Adjustment to reconcile basic EPS to non-GAAP
                                               
basic EPS:
                                               
  Impact of stock-based compensation, net of tax effect
   
0.04
     
(0.01
)
   
0.03
     
0.14
     
-
     
0.14
 
  Impact of amortization of acquisition intangibles, net of tax effect
   
0.03
     
-
     
0.03
     
0.12
     
-
     
0.12
 
  Impact of acquisition transaction costs, restructuring, and other, net of tax effect
   
-
     
-
     
-
     
0.02
     
-
     
0.02
 
   Impact of acquisition-related fair value adjustments, net of tax effect
   
0.01
     
-
     
0.01
     
0.01
     
-
     
0.01
 
Non-GAAP basic EPS
   
0.34
     
(0.04
)
   
0.30
     
0.97
     
(0.04
)
   
0.93
 
 
                                               
 
                                               
Diluted EPS, as reported
   
0.26
     
(0.03
)
   
0.23
     
0.68
     
(0.04
)
   
0.64
 
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS
                                               
  Impact of stock-based compensation, net of tax effect
   
0.04
     
(0.01
)
   
0.03
     
0.14
     
-
     
0.14
 
  Impact of amortization of acquisition intangibles, net of tax effect
   
0.03
     
-
     
0.03
     
0.12
     
-
     
0.12
 
  Impact of acquisition transaction costs, restructuring, and other, net of tax effect
   
-
     
-
     
-
     
0.02
     
-
     
0.02
 
   Impact of acquisition-related fair value adjustments, net of tax effect
   
0.01
     
-
     
0.01
     
0.01
     
-
     
0.01
 
Non-GAAP diluted EPS
   
0.34
     
(0.04
)
   
0.30
     
0.97
     
(0.04
)
   
0.93
 
 
                                               
Weighted average shares outstanding -
                                               
Basic
   
129,108
     
-
     
129,108
     
128,453
     
-
     
128,453
 
Diluted
   
129,503
     
-
     
129,503
     
129,008
     
-
     
129,008
 




National Instruments
 
Reconciliation of Net Income to EBITDA
 
(in thousands, unaudited)
 
                                     
   
Three Months Ended Dec. 31, 2016
   
Year Ended Dec. 31, 2016
 
   
As furnished on January 26, 2017
   
Impact of revision
   
As furnished on February 16, 2017
   
As furnished on January 26, 2017
   
Impact of revision
   
As furnished on February 16, 2017
 
                                     
Net income, as reported
   
33,830
     
(4,681
)
   
29,149
     
87,415
     
(4,681
)
   
82,734
 
Adjustments to reconcile net income to EBITDA:
           
-
                     
-
         
     Interest income, net
   
(155
)
   
-
     
(155
)
   
(349
)
   
-
     
(349
)
     Tax expense
   
13,065
     
4,681
     
17,746
     
27,220
     
4,681
     
31,901
 
     Depreciation and amortization
   
18,226
     
-
     
18,226
     
73,390
     
-
     
73,390
 
EBITDA
   
64,966
     
-
     
64,966
     
187,676
     
-
     
187,676
 
Weighted average shares outstanding - Diluted
   
129,503
     
-
     
129,503
     
129,008
     
-
     
129,008
 

Non-GAAP Presentation
In addition to disclosing results determined in accordance with GAAP, NI discloses certain non-GAAP operating results and non-GAAP information that exclude certain charges. In this Current Report on Form 8-K, NI has presented its provision for income taxes, net income and basic and fully diluted EPS for the three- and twelve-month periods ending Dec. 31, 2016 on a GAAP and non-GAAP basis.
When presenting non-GAAP information, NI includes a reconciliation of the non-GAAP results to the GAAP results. NI believes that including the non-GAAP results assists investors in assessing the company's operational performance and its performance relative to its competitors.  NI presents these non-GAAP results as a complement to results provided in accordance with GAAP, and these results should not be regarded as a substitute for GAAP. NI uses these non-GAAP measures to manage and assess the profitability and performance of its business and does not consider stock-based compensation expense, amortization of acquisition-related intangibles, acquisition-related transaction costs, taxes levied on the transfer of acquired intellectual property, foreign exchange loss on acquisitions, acquisition-related fair value adjustments, and restructuring charges in managing its operations. Specifically, NI uses non-GAAP measures to plan and forecast future periods; to establish operational goals; to compare with its business plan and individual operating budgets; to measure management performance for the purposes of executive compensation, including payments to be made under bonus plans; to assist the public in measuring the company's performance relative to the company's long-term public performance goals; to allocate resources; and, relative to the company's historical financial performance, to enable comparability between periods. NI also considers such non-GAAP results to be an important supplemental measure of its performance.
This Current Report on Form 8-K discloses NI's EBITDA for the three- and twelve- month periods ending Dec. 31, 2016. NI believes that including the EBITDA results assists investors in assessing the company's operational performance relative to its competitors. A reconciliation of EBITDA to GAAP net income is included with this Current Report on Form 8-K.
Forward-Looking Statements

The foregoing statement whereby NI is confirming, as of the date hereof, its financial guidance previously furnished in the Form 8-K dated January 26, 2017 is a "forward-looking statement" that is subject to a number of risks and uncertainties, including the risk of adverse changes or fluctuations in the global economy, foreign exchange fluctuations, fluctuations in demand for NI's products including orders from its largest customer, component shortages, delays in the release of new products, NI's ability to effectively manage its operating expenses, manufacturing inefficiencies and the level of capacity utilization, the impact of any recent or future acquisitions, expense overruns, adverse effects of price changes or effective tax rates. Actual results may differ materially from the expected results.   NI directs readers to its Form 10-K for the year ended Dec. 31, 2015, its Form 10-Q for the quarter ended Sept. 30, 2016; and the other documents it files with the SEC for other risks associated with the company's future performance.



 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
NATIONAL INSTRUMENTS CORPORATION
 
 
 
 
By:
/s/ DAVID G. HUGLEY
 
 
 
David  G. Hugley
Vice President & General Counsel; Secretary

Date:  February 16, 2017